Results 31 to 40 of about 1,625,836 (186)

Serum levels of antipsychotic agents.

, 2012
Fasting serum levels of antipsychotic agents, given in nM, after 2 or 8 weeks of treatment, respectively.
Vidar Martin Steen (116127), Pavol Bohov (116122), Silje Skrede (116112), Johan Fernø (116115), Wenche Rødseth Brede (116120), Bodil Bjørndal (116118), Rolf Kristian Berge (116124)   +6 more
core   +1 more source

Cognitive therapy for people with a schizophrenia spectrum diagnosis not taking antipsychotic medication:an exploratory trial [PDF]

, 2011
Background. Although antipsychotic medication is the first line of treatment for schizophrenia, many service users choose to refuse or discontinue their harmacological treatment.
Hutton, P., Dudley, R., Wardle, M., Brabban, A, Tai, S. J., French, P., Callcott, Pauline, P. Callcott, R. Dudley, Turkington, Douglas, Callcott, P, P. Hutton, A. P. Morrison, Lumley, Victoria, Wardle, Melissa, Christodoulides, Thomas, Dudley, Robert, A. Brabban, P. French, Hutton, Paul, Tai, S.J., Barratt, S., M. Wardle, Spencer, H., Barratt, Sarah, Brabban, A., T. Christodoulides, Dudley, R, S. J. Tai, V. Lumley, French, P, Turkington, D, H. Spencer, Christodoulides, T., Christodoulides, T, D. Turkington, Spencer, H, Morrison, A. P., S. Barratt, Lumley, V., Brabban, Alison, Spencer, Helen, Callcott, P., Tai, Sara J, French, Paul, Lumley, V, Morrison, Anthony P, Turkington, D., Barratt, S, Wardle, M   +49 more
core   +1 more source

Assessment of adherence to treatment with injectable extended-release antipsychotics within a pharmacotherapeutic follow-up program [PDF]

Farmacia Hospitalaria, 2019
Objective: To describe an injectable extended-release antipsychotic pharmacotherapeutic follow-up program and to assess adherence among patients included in the program.
Carmen Gallastegui, Hadriana Fernández-Vega, Guadalupe Piñeiro, Isabel Rey-Gómez-Serranillos, José M. Olivares, Elena de las Heras-Liñero   +5 more
doaj   +1 more source

Neuroleptic malignant syndrome

Journal of Family Medicine and Primary Care, 2016
Neuroleptic malignant syndrome (NMS) is a life-threatening emergency that is often seen as a complication of antipsychotic agents. It is characterized by a tetrad of motor, behavioral, autonomic, and laboratory abnormalities.
Bino Rajamani, Yashwant Kumar, Sajitha M.F. Rahman   +2 more
doaj   +1 more source

Existing and emerging pharmacological approaches to the treatment of mania: A critical overview

Translational Psychiatry, 2022
Manic episodes are a defining, frequent and dramatically disabling occurrence in the course of Bipolar Disorder type I. Current pharmacotherapy of mania lists a good number of agents, but differences in efficacy and safety profiles among these agents ...
Giulio Sparacino, Norma Verdolini, Eduard Vieta, Isabella Pacchiarotti   +3 more
doaj   +1 more source

Risk of Mortality (including Sudden Cardiac Death) and Major Cardiovascular Events in Users of Olanzapine and Other Antipsychotics: A Study with the General Practice Research Database. [PDF]

, 2013
Objective. Assess risk of cardiac events and mortality among users of olanzapine and other antipsychotics relative to nonusers. Methods. The General Practice Research Database was used to identify cohorts of antipsychotic users and nonusers with ...
Van Staa, Tjeerd; id_orcid, Murray-Thomas, Tarita, Motsko, Stephen, Brunner, Elizabeth, Jones, Meghan E, Campbell, Giedra, Patel, Deven, van Staa, Tjeerd P, Shatapathy, Chetan C   +8 more
core   +1 more source

CLOZAPINE AND HALOPERIDOL INCREASE THE EXPRESSION OF PED/PEA-15: A PUTATIVE NOVEL MECHANISM FOR ANTIPSYCHOTIC-RELATED DIABETES [PDF]

, 2008
Schizophrenia is a serious disorder that affects 1% of the population in the United States and Europe, and is associated with a significant reduction in life expectancy that approaches 20% compared with that of the general population.
Panariello, Fabio
core   +1 more source

Antipsychotic treatment patterns and cardiometabolic medicine use: current real-world evidence

Epidemiology and Psychiatric Sciences
Aims Off-label use of antipsychotics, often at low doses, is increasing. Exploring the link between individual antipsychotic treatment patterns, including low-dose continuous use, and cardiometabolic health is crucial to prevent long-term morbidity and ...
Ramya Padmavathy Radha Krishnan, Helga Zoega, Nicholas A Buckley, Jacques Eugene Raubenheimer   +3 more
doaj   +1 more source

Do Atypical Antipsychotic Agents Trigger Autoimmune Diabetes?

, 2016
Atypical or second-generation antipsychotic agents, such as aripiprazole and olanzapine, are increasingly used in the management of schizophrenia and bipolar disorders in children.
Soyka, Leslie A., Nwosu, Benjamin U., Hardy, Olga T., Angelescu, Amanda, Lee, Mary M.   +4 more
core   +1 more source

Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors [PDF]

, 1994
The authors examined the affinities of 36 typical and atypical antipsychotic agents for the cloned rat 5-hydroxytryptamine-6 (5-HT6) and rat 5-hydroxytryptamine-7 (5-HT7) receptors in transiently expressed COS-7 cells (5-HT7) or stably transfected HEK ...
Sibley, David R., Shen, Y., Roth, Bryan L., Craigo, Sean C., Choudhary, M. Salman, Meltzer, Herbert Y., Uluer, A., Monsma, Frederick J., Jr.   +7 more
core   +1 more source